(Q51033723)

27 March 2018

title

Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. (English)

1 reference

27 March 2018

0 references

5

1 reference

27 March 2018

author name string

Donna Mahony

1

1 reference

27 March 2018

Antonino S Cavallaro

2

1 reference

27 March 2018

Frances Stahr

3

1 reference

27 March 2018

Timothy J Mahony

4

1 reference

27 March 2018

Neena Mitter

6

1 reference

27 March 2018

publication date

26 April 2013

1 reference

27 March 2018

published in

Small

1 reference

27 March 2018

volume

9

1 reference

27 March 2018

issue

18

1 reference

27 March 2018

page(s)

3138-3146

1 reference

27 March 2018

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Proteins in mesoporous silicates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Improving adsorbent properties of cage-like ordered amine functionalized mesoporous silica with very large pores for bioadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

pH-Controllable drug release using hydrogel encapsulated mesoporous silica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Advances in saponin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

New adjuvants for human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

On the controllable soft-templating approach to mesoporous silicates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

Porous Silica Nanospheres Functionalized with Phosphonic Acid as Intermediate-Temperature Proton Conductors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300012

21 January 2018

Identifiers

DOI

10.1002/SMLL.201300012

1 reference

27 March 2018

1 reference

27 March 2018